Denis Chem Lab Experiences Revision in Stock Evaluation Amid Strong Financial Performance
Denis Chem Lab has recently experienced a revision in its score by MarketsMojo, reflecting a notable adjustment in its evaluation. This change follows the company's strong financial performance, marked by impressive operating cash flow and net sales figures. The stock has also been added to MarketsMojo's list, highlighting its market significance.
Denis Chem Lab, a microcap player in the plastic products industry, has recently seen an adjustment in its evaluation by MarketsMOJO, which has upgraded the stock's call to 'Hold' as of January 6, 2025. This revision comes on the heels of the company's strong financial performance, highlighted by impressive operating cash flow and net sales figures for September 2024. Denis Chem Lab reported its highest operating cash flow at Rs 17.60 crore and net sales reaching Rs 47.82 crore, showcasing its robust operational capabilities. The company also maintains a low Debt to EBITDA ratio of 0.48 times, indicating a strong ability to service its debt obligations. With a return on equity of 14 and a price-to-book value of 2.6, the stock is viewed as having a very attractive valuation.
Despite these positive indicators, the company has faced challenges in long-term growth, with net sales and operating profit growing at annual rates of 5.75% and 12.38%, respectively, over the past five years. Additionally, the stock is currently positioned in a mildly bearish technical range, reflecting some recent volatility. Notably, Denis Chem Lab has been added to MarketsMOJO's list, further emphasizing its market presence.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
